PANCREATIC

Clinical trials for PANCREATIC explained in plain language.

Never miss a new study

Get alerted when new PANCREATIC trials appear

Sign up with your email to follow new studies for PANCREATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New 'Living Drug' trial targets deadly cancer mutation

Disease control Ongoing

This early-stage study is testing a new type of personalized cell therapy for people with advanced colorectal, pancreatic, or non-small cell lung cancer. The therapy involves collecting a patient's own immune cells, genetically modifying them to target a specific cancer-causing m…

Matched conditions: PANCREATIC

Phase: PHASE1 • Sponsor: Corregene Biotechnology Co., Ltd • Aim: Disease control

Last updated Mar 23, 2026 15:28 UTC

PANCREATIC

Get alerted when new PANCREATIC trials appear

New 'Living Drug' trial targets deadly cancer mutation